Stocks and Investing Stocks and Investing
Thu, November 14, 2019
Wed, November 13, 2019
Tue, November 12, 2019
Mon, November 11, 2019
Fri, November 8, 2019

David Amsellem Maintained (TEVA) at Hold with Increased Target to $7 on, Nov 8th, 2019


Published on 2024-10-26 18:04:39 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $6 to $7 on, Nov 8th, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Monday, September 30th, 2019
  • Rohit Vanjani of "Guggenheim" Initiated at Hold on, Thursday, September 12th, 2019
  • Vamil Divan of "Credit Suisse" Initiated at Hold on, Wednesday, July 10th, 2019


These are the ratings of the 2 analyists that currently disagree with David


  • Chris Schott of "JP Morgan" Maintained at Sell with Decreased Target to $7 on, Friday, September 6th, 2019
  • David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $6 on, Monday, July 15th, 2019